How should melatonin be used (dose, timing, duration, and contraindications) for a healthy adult with difficulty falling asleep due to delayed sleep phase, shift work, or jet lag?

Melatonin for Sleep in Healthy Adults

For delayed sleep phase disorder, start with 3–5 mg of immediate-release melatonin taken 1.5–2 hours before your desired bedtime (typically between 19:00–21:00), continue for at least 28 days, and use a USP-verified formulation to ensure reliable dosing. 1, 2

Dosing Strategy by Indication

Delayed Sleep-Wake Phase Disorder (DSWPD)

• Begin with 5 mg of melatonin administered between 19:00–21:00 (approximately 1.5–2 hours before desired sleep onset) for a minimum treatment duration of 28 days. 2
• The American Academy of Sleep Medicine provides a weak recommendation FOR strategically timed melatonin in adults with DSWPD (including those with depression), though the evidence quality is rated as LOW. 1
• Clinical trials demonstrate that this regimen increases total sleep time by 56 minutes and decreases sleep latency by 37.7 minutes in adults without depression. 2
• If starting conservatively, use 3 mg immediate-release melatonin and titrate upward in 3 mg increments after 1–2 weeks if ineffective, with a practical ceiling of 5 mg for circadian disorders. 2, 3

Shift Work Sleep Disorder

• Apply the same 3–5 mg dosing strategy, but time administration 1.5–2 hours before the intended sleep period (which will vary based on your shift schedule). 2, 4
• Melatonin helps hasten adaptation of circadian rhythms to imposed schedules and enhances both sleep quality and subsequent alertness during work periods. 4
• Critically, if timed incorrectly (e.g., taken during your desired wake period), melatonin will worsen circadian misalignment and impair alertness—timing is more important than dose. 1, 4

Jet Lag

• For flights crossing fewer than 7–8 time zones, take 3–5 mg of melatonin at the local bedtime of your destination for 2–4 nights after arrival. 5
• For flights crossing more than 7–8 time zones, begin melatonin 2–3 days before departure at the destination bedtime (converted to your home time zone) to pre-adapt your circadian rhythm. 5
• This pre-flight strategy carries the risk of unwanted daytime somnolence at home; an alternative is to use strategic light exposure (bright light avoidance and seeking) combined with post-arrival melatonin at destination bedtime. 5

Critical Timing Principles

Melatonin's phase-response curve is approximately 180 degrees out of phase with light: dosing in the afternoon/evening (before your core body temperature minimum) advances circadian rhythms earlier, while morning dosing delays them later. 1

• The dim-light melatonin onset (DLMO) serves as the approximate inflection point—melatonin taken before DLMO advances your clock, after DLMO delays it. 1
• For delayed sleep phase, you want to advance your clock earlier, so administer melatonin 4–6 hours before your current habitual sleep onset (typically 19:00–21:00 for someone falling asleep at 02:00). 1, 2
• Never take melatonin in the morning or afternoon for delayed sleep phase, as this will paradoxically worsen your circadian misalignment. 6

Treatment Duration and Reassessment

• For DSWPD, continue melatonin for at least 28 days to evaluate effectiveness; circadian adaptation is gradual and requires sustained treatment. 2
• For shift work and jet lag, use melatonin only during the period of circadian disruption—typically 2–7 days for jet lag, or on an ongoing basis during rotating shift schedules. 7, 5
• The American Academy of Sleep Medicine recommends against long-term daily melatonin use (beyond 3–4 months) for primary insomnia due to insufficient long-term safety data, though ongoing use for circadian rhythm disorders may be appropriate. 6, 3
• Reassess need for continued therapy every 3–6 months; attempt periodic dose reduction or intermittent dosing (every other night) to determine the lowest effective regimen. 3

Formulation and Quality Considerations

• Choose immediate-release melatonin over prolonged-release formulations for delayed sleep phase and jet lag, as immediate-release better targets sleep onset and circadian phase shifting. 6
• Prolonged-release melatonin (2 mg) is designed for sleep maintenance in elderly patients and is less effective for circadian phase shifting. 6
• Select products with the United States Pharmacopeial Convention (USP) Verified Mark, as melatonin is regulated as a dietary supplement in the U.S. and unverified products show significant variability in actual melatonin content. 2, 3

Dose-Response Relationship

Lower doses (0.5–5 mg) are often as effective as higher doses (10 mg) and cause fewer adverse effects; timing is more critical than dose for circadian effects. 1, 3

• Doses above 5 mg may cause receptor desensitization or saturation, potentially disrupting normal circadian signaling and increasing morning grogginess. 3
• The phase-response curve for doses above 5 mg has not been published, and higher doses primarily add soporific (sleep-inducing) effects rather than enhanced circadian shifting. 1
• Morning headache, daytime sleepiness, and gastrointestinal upset occur more frequently at doses above 6 mg. 3

Safety Profile and Contraindications

• Melatonin demonstrates a favorable safety profile with adverse event rates comparable to placebo; the most common side effect is intended drowsiness when taken at the appropriate time. 6
• Daytime somnolence occurs in 1.66% of users, headache in 0.74%, and dizziness in 0.74%. 6, 3
• Use caution in patients taking warfarin, as case reports document potential interactions; monitor INR more frequently if combining these agents. 2, 3
• Exercise caution in patients with epilepsy based on case reports of potential interactions. 2, 3
• No clinically significant interactions exist between melatonin and common medications including SSRIs, beta-blockers, or other CNS-active agents, though monitor for additive sedation. 6
• Avoid alcohol consumption, which interacts with melatonin and can worsen sleep architecture. 6

Common Pitfalls to Avoid

• Taking melatonin at bedtime (rather than 1.5–2 hours before) fails to optimally synchronize circadian rhythms and reduces therapeutic efficacy. 6
• Using melatonin as a simple "sleeping pill" for primary insomnia in young healthy adults is not evidence-based; the American Academy of Sleep Medicine gives a weak recommendation AGAINST this practice. 6
• Administering melatonin at the wrong circadian phase (e.g., morning dosing for delayed sleep phase) will worsen your condition rather than improve it. 4
• Expecting immediate results—circadian adaptation requires consistent dosing for at least 1–2 weeks before meaningful improvement occurs. 2
• Combining melatonin with excessive caffeine intake (particularly after 14:00) counteracts melatonin's effects and should be avoided. 6

When Melatonin Is NOT Appropriate

• The American Academy of Sleep Medicine recommends AGAINST melatonin for primary insomnia in otherwise healthy adults without circadian rhythm disruption, as benefits roughly equal harms. 6
• Cognitive-behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia and produces superior long-term outcomes compared to any pharmacologic agent. 6
• If sleep difficulty is due to sleep apnea, restless legs syndrome, or other primary sleep disorders rather than circadian misalignment, melatonin will not address the underlying problem. 1